Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alphapharm is a leading Australian pharmaceutical company that specializes in the development and supply of generic and biosimilar medicines. Founded in 1982, the company has grown to become one of the largest suppliers of prescription drugs to the Australian Pharmaceutical Benefits Scheme (PBS). It operates a major manufacturing facility in Carole Park, Queensland, which produces billions of doses of medicine annually for domestic and international markets. In 2007, Alphapharm was acquired by Mylan, and it is now a key part of Viatris following the 2020 merger of Mylan and Pfizer's Upjohn division. The company's extensive portfolio covers a wide range of therapeutic areas, including cardiovascular health, oncology, and central nervous system disorders. Alphapharm remains a critical infrastructure component of the Australian healthcare system, ensuring the availability of affordable essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alphapharm Party.